|
America's online pharmacy serving your needs for no prescriptions Your right decision! Click Here ... |
Casodex Information
THERAPEUTIC ACTION: antiandrogen. PHARMACOLOGY: Pharmacodynamics: CASODEX is a non-steroidal anti-androgen drug that binds to cytosolic androgen receptors and competes to inhibit the uptake or binding of androgens in specific tissues, thus interfering with the actions of androgens at the cellular level. Because prostate cancer is androgen-sensitive, action CASODEX inhibits growth and leads to tumor regression. When these effects are complemented by antiandrogens administration of LHRH agonists or bilateral orchiectomy, there is inhibition or cessation of testicular production (but not adrenal). When administered with an LHRH analogue, inhibits the nonsteroidal antiandrogen temporary elevation of testosterone in plasma and the reaction of activity that may occur prior to the sustained decline in testosterone production that occurs when installing monotherapy with an LHRH analogue. Other effects: when the non-steroidal anti-androgen is administered alone, it inhibits the negative feedback response to testosterone by the hypothalamus. In patients who are not surgical castration under this effect results in an increase in serum testosterone and, consequently, estrogen. The administration of an LHRH analogue inhibits the effect of encouraging non-steroidal anti-androgen (but not the suppressive effect of LHRH analogue) on serum testosterone. Pharmacokinetics Absorption: CASODEX is well absorbed after oral administration and is not altered in the presence of food. Plasma protein binding: 98%. Biotransformation: Hepatic metabolism extensive steroid specific. The active R-enantiomer is metabolized primarily by oxidation to an inactive metabolite. The active S-enantiomer is metabolized by glucuronidation. Elimination half-life: 5.8 to 7 days for the active R-enantiomer. The time is prolonged in patients with severe liver dysfunction. Time to peak concentration is: 31.3 hours for the active R-enantiomer. Peak serum concentration is: 0.768mcg/ml. Serum Stable 9mcg/ml average (99% for the R-enantiomer) followed by a dose of 50mg per day of Bicalutamide (bicalutamide). Elimination: kidney 34% and faecal 43% of the administered dose within 9 days, as derived glucuronides. Not affect renal dysfunction.
Undesirable effects of Casodex:
In general, CASODEX has been well tolerated, and there have been few dropouts due to adverse reactions. Most common effects (= 10%): respiratory infection, including lung and upper airways (cough, fever, rhinorrhea, dyspnea, sore throat). General: constipation or diarrhea, nausea, weakness, flushing. Less common effects (> 1% to <10%): anemia, dyspnea, edema, fever, gastrointestinal or rectal bleeding, hypertension (usually asymptomatic), skin itching, mental depression, neuropathy, neuromuscular symptoms (dizziness, pain, tingling muscle weakness in hands, arms, feet and legs), pulmonary disorders (chest pain, coughing, shortness of breath or labored), skin rashes, bloating, indigestion, confusion, constipation, decreased appetite, dizziness, drowsiness, dry mouth, flu syndrome, gynecomastia, headache, impotence or decreased sexual desire, nervousness, restless sleep, vómitos. Efectos rare (<1%): hepatitis or jaundice, including cholestatic jaundice (dark urine, gastric symptoms, decreased appetite, yellowing of skin and eyes, malaise, right upper quadrant). Unknown effects: leukopenia usually asymptomatic, methaemoglobinaemia usually asymptomatic, alcohol intolerance (dizziness, despondency, flushing, malaise), disruption of visual adaptation to darkness, visual disturbances including chromatopsia (changes in color vision) to modify or change increased sensitivity to light and casodex psa.
Indications of Casodex:
Treatment of advanced prostate cancer in combination with treatment with an LHRH analogue or surgical castration.
Casodex drug cautions and warnings:
CONTRAINDICATIONS: Contraindicated in women and children. CASODEX not be administered to any patient who has submitted a hypersensitivity reaction to the Bicalutamide (bicalutamide) during previous treatment. To moderate hepatic insufficiency says prognosis when lupron and casodex are combined WARNING: Carcinogenicity / tumorigenicity: the Bicalutamide (bicalutamide) caused testicular interstitial tumor benign uterine carcinoma in animal models and a small rise in the incidence of hepatocellular carcinoma. There were no tumourigenic effects suggestive of genotoxic carcinogenesis. Hyperplasia of Leydig cells has not been observed in humans who receive Bicalutamide (bicalutamide). Mutagenicity: Bicalutamide (bicalutamide) has reported no genotoxic effects in vivo or in vitro. Pregnancy and Reproduction: The Bicalutamide (bicalutamide) inhibits spermatogenesis, but its effects on male fertility have not been studied long term. In animal models the effects reversal 7 days after 11 weeks of treatment. However, casodex side effects produced a reduction in anogenital region, hypospadias and impotence. Category FDA for use in pregnancy: X. Lactation It is not known whether the Bicalutamide (bicalutamide) is distributed into breast milk: however, should not be used in breastfeeding because of the potential in children who makes casodex. Effect on ability to drive a car or operate machinery: it is unlikely that bicalutamide (bicalutamide) alters the ability of patients to drive a car or operate machinery. Pediatrics: No studies of safety and efficacy of bicalutamide (bicalutamide) in children. Possible disruption of sexual development may occur in young males. Geriatrics: Bicalutamide (bicalutamide) 50mg daily dose in geriatric population reported no significant elevation of serum concentration of the drug compared to younger adults. Laboratory values: the Bicalutamide (bicalutamide) can cause elevated liver enzymes (ALT, AST), alkaline phosphatase, bilirubin and the serum creatinine. Estradiol or testosterone may be elevated when the Bicalutamide (bicalutamide) is not administered with an LHRH analogue. Bicalutamide (bicalutamide) can cause elevation of serum glucose. Bicalutamide (bicalutamide) can lower levels of Hb or WBC. INTERACTIONS: CASODEX might displace the coumarin anticoagulant warfarin, from its binding sites to proteins, therefore, to start treatment with casodex generic in patients already receiving coumarin anticoagulants, it is recommended to closely monitor prothrombin time and INR. CONSERVATION: Store at less than 30C. OVERDOSE: Not established the single dose of cheap casodex that could endanger the patient’s life. Doses of 200mg per day have been well tolerated in clinical studies. It has also shown low toxicity in animals buy Casodex. It is estimated that 2000mg/kg dose could cause death in rats. No specific antidote for overdose. Vomiting can be induced in awaken patients without disorders of consciousness because of casodex product handling. Dialysis does not remove the Bicalutamide (bicalutamide) from the blood significantly. Recommended general supportive measures, monitoring of vital functions and observation are recommended.
You can purchase this medication and other prescription drugs or prescription at lowest cost from our online pharmacy in Canada. Online Drug store offers generic medications via the Internet or at the best price and casodex pain relief prostate bone cancer.
